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Context: Skeletal muscle and cardiac lipid accumulation are associated with diminished insulin
sensitivity and cardiac function, respectively. In skeletal muscle, physical activity paradoxically
increases fat accumulation, despite improvement in insulin sensitivity. Whether cardiac muscle
responds similarly remains unknown.
Objective: The objective of the study was to investigate cardiac lipid content and cardiac function
after a 12-wk training program.
Design: This was an intervention study with pre/postmeasurements.
Setting: The study was conducted at Maastricht University Medical Center.
Participants: Participants included 14 healthy, male overweight/obese subjects (age 58.4  0.9 yr,
body mass index 29.9  0.01 kg/m2).
Intervention: Intervention included a supervised 12-wk training program with three sessions per
week (endurance and strength training).
Main Outcome Measures: Maximal whole-body oxygen uptake, fasting plasma parameters, sys-
tolic function (by CINE-magnetic resonance imaging), and cardiac lipid content (by proton mag-
netic resonance spectroscopy) were measured.
Results: Maximal whole-body oxygen uptake increased (from 2559  131 to 2702  124 ml/min after
training, P  0.05). Plasma concentrations of glucose decreased (from 6.3  0.2 to 5.7  0.2 mmol/liter,
P  0.001); plasma triacylglycerols and (free) fatty acids did not change. Also, body weight (from 94.2 
3.6 to 92.9  3.6 kg, P  0.10) and fat percentage (from 33.6  1.7 to 32.5  2.0%, P  0.14) was
unchanged. Left ventricular ejection fraction improved (from 52.2  1.3 to 54.2  1.2%, P  0.02), and
cardiac lipid content in the septum was decreased after training (0.99 0.15 to 0.54  0.04%, P  0.02).
Conclusions: Twelve weeks of endurance/strength training significantly reduced cardiac lipid content
in overweight subjects and was paralleled by improved ejection fraction. This is in line with a lipotoxic
action of (excess) cardiac lipids on cardiac function, although a causal relationship cannot be derived
from this study. Further research is needed to clarify the clinical relevance of cardiac lipid content in the
etiology of cardiovascular complications. (J Clin Endocrinol Metab 95: 1932–1938, 2010)
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The prevalence of obesity has reached epidemic propor-tions and is still increasing (1). Obesity is a major risk
factor for the development of cardiovascular diseases (2,
3) and an independent risk factor for the development of
heart failure (4). Obesity is associated with excessive stor-
age of lipids (triglycerides) not only in adipose tissue but
also in skeletal muscle, liver, and heart. Increased lipid
storage in skeletal muscle and the liver is strongly associ-
ated with insulin resistance. Likewise, high intracellular
lipid concentrations may also have negative effects in the
heart: in animal models, there is convincing evidence that
excessive lipid storage in cardiomyocytes can induce car-
diomyopathy and heart failure via lipotoxic pathways.
This was initially shown in various animal models of obe-
sity (5,6)butmore recently also in lean rodentmodelswith
targeted overexpression of genes involved in lipid delivery
and synthesis in the myocardium (7–11). These animals
show steatosis-induced dilated cardiomyopathy and heart
failure in the absence of obesity-related cardiovascular risk
factors (such as hypertension or dyslipidemia) (7–11), indi-
cating that lipid accumulation in the myocardium can cause
cardiomyopathy directly. In line with this, treatments that
ameliorated cardiac lipid accumulation rescued the heart
from dilated cardiomyopathy in rodents (6, 11–14).
A more physiological model for human obesity-related
cardiac lipid accumulation is embodied by rats on a high-
fat diet. Consumption of such a high-fat diet results in
cardiac lipid accumulation, paralleled by contractile dys-
function (15) and changes in intracellular signaling path-
ways leading to a decreased insulin responsiveness of car-
diac cells (15).
Whether myocardial lipid accumulation is also of clinical
relevance is less obvious. In humans, investigating cardiac
lipidcontentandits subcellularconsequences ishamperedby
the difficulty of obtaining cardiac tissue. Therefore, until re-
cently,onlypostmortemortransplantationstudieswerepos-
sible (16). However, the demonstration of reliable cardiac
lipid quantification with electrocardiogram (ECG)-triggered
and respiratory-gated magnetic resonance spectroscopy
(MRS), makes in vivo evaluations possible and enables in-
terventional studies (17–19).
Physical exercise training improved diastolic function
in overweight subjects and decreased end-systolic left ven-
tricular volume in overweight subjects (20) and hence pos-
itively affects cardiovascular health. Furthermore, regular
physical activity can reverse age-induced decline in cardiac
energy status (21). If cardiac lipid content is indeed det-
rimental, it can thus be hypothesized that endurance train-
ing will decrease cardiac lipid content, thereby allowing
improvement of cardiac function. On the other hand, in
skeletal muscle, endurance training increases rather than
decreases muscular lipid content (intramyocellular lipids)
(22), probably because endurance-trained muscles need
larger internal fat depots for oxidation during exercise.
Therefore, endurance training is an exception to the rule
that lipid storage in skeletal muscle is unhealthy.
So far, it is unknown whether in cardiac muscle, which
is also heavily depending on fatty acid oxidation, also such
a paradox exists. If this is the case, cardiac lipid depots
would be expanded rather than reduced with physical ac-
tivity training and as a consequence, cardiac lipid content
would not be a good marker for cardiac lipotoxicity.
Therefore, the aim of the present study was to investigate
the change in cardiac lipid content and cardiac function in
response to a physical training intervention in overweight
subjects.Tothisend,weused 1H-MRSandCINE-magnetic
resonance imaging (MRI) to determine cardiac lipid con-
tent and cardiac function before and after a progressive
training program of 12 wk.
Subjects and Methods
Subjects
Fourteen healthy male overweight to obese individuals were
included in this study. For other characteristics, see subjects’
characteristics in Table 1. The study was approved by the insti-
tutional medical ethical committee and written informed consent
was obtained from all participants.
Study protocol
Before inclusion, all subjects underwent a medical examina-
tion including the assessment of their medical history and a phys-
ical examination. Also an ECG was registered, blood pressure
TABLE 1. Subjects’ characteristics before and after the





Age (yr) 58.4  0.9 n/a n/a
Body weight (kg) 94.2  3.6 92.9  3.6 0.1
Fat percentage (%) 33.6  1.7 32.5  2.0 0.14
Body mass index
(kg/m2)
29.9  0.01 29.5  0.01 0.1
VO2max
(ml/kg  min)
27.2  1.4 30.3  1.7 0.01a
Glucose (mmol) 6.3  0.2 5.7  0.2 0.001a
HbA1c (%) 5.9  0.8 5.8  0.1 0.01a
FAs (mol/liter) 384.3  37.8 364.5  24.4 0.6
Triacylglycerols
(mmol/liter)
1.36  0.1 1.35  0.1 0.9
Total cholesterol
(mmol/liter)
5.63  0.22 5.30  0.25 0.02a
LDL cholesterol
(mmol/liter)
3.74  0.20 3.41  0.23 0.01a
HDL cholesterol
(mmol/liter)
1.28  0.07 1.27  0.07 0.7
n/a, Not applicable.
a Statistically significant changes.









aastricht user on 27 Septem
ber 2021
was assessed, and a fasting blood sample was taken to determine
glucose and glycated hemoglobin (HbA1c) concentrations. High
blood pressure (systolic blood pressure 160 mm Hg or diastolic
blood pressure 100 mm Hg) was an exclusion criterion as well
as known cardiac disease and type 2 diabetes mellitus. Two sub-
jects were on blood pressure-lowering drugs (one subject on a
combination drug of an angiotensin-converting enzyme inhibi-
tor and a diureticum, one subject on a selective Ca2 channel
blocker) and continued medication throughout the study.
As part of the experiment, the following parameters were
measured before and after a 12-wk training intervention: body
composition, maximal oxygen uptake, plasma concentration of
(free) fatty acids (FAs), triacylglycerols, glucose, HbA1c, and
cholesterol. 1H-MRS and MRI were used to determine in vivo
cardiac lipid content next to ejection fraction, cardiac index, and
cardiac output as indicators of cardiac function. Heart rate dur-
ing a standardized exercise protocol was registered before and
after the training program as an additional indicator of cardiac
function. Two subjects were taking lipid-lowering medication
(statins), which was continued throughout the study with un-
changed dosage. Please note that when these subjects were ex-
cluded from analysis, the training-induced effects on ejection
fraction and cardiac lipid content remain statistically significant.
Subjects were asked to continue their habitual diet throughout
the study. The 2 d preceding the determination of cardiac lipid
content, subjects were used to refrain from alcohol, adhere to a
normal eating pattern, and refrain from intense exercise. The
measurement was performed in the morning in the fasted state.
Training protocol
All subjects were engaged in a highly controlled exercise pro-
gram for 12 wk, consisting of a combination of aerobic and
resistance exercise. The aerobic exercise was carried out on a
cycling ergometer twice a week for 30 min at 55% of their pre-
determined maximal workload. After 6 wk maximal perfor-
mance was reassessed and the intensity of the training adjusted.
Resistance exercise was performed once a week and consisted of
one series of eight repetitions at 55% of their maximal voluntary
contraction (MVC) and two series of eight repetitions at 75%
MVC. A series of eight exercises concentrating on large muscle
groups were performed (chest press, leg extension, lat pull-down,
leg press, triceps curls, biceps curls, abdominal crunches, hori-
zontal row). All training sessions were preceded by a 5 min
warm-up and ended with 5 min of cooling down on the cycle
ergometer at 45% of maximal workload. Every 4 wk, MVC was
reassessed, and the exercise intensity was adjusted if necessary.
All exercise sessions were carried out in small groups of four
subjects, supervised by a coach.
Maximal oxygen uptake (VO2max; whole body
oxidative capacity)
A routine incremental cycling test was used to determine the
maximal aerobic capacity as described previously (23). Briefly,
after a warming-up period of 5 min, the intensity was increased
every 2.5 min until exhaustion. Oxygen consumption was mea-
sured continuously throughout the test using indirect calorime-
try (Oxycon , Mijnhardt, The Netherlands) to determine
VO2max.
Heart rate at submaximal exercise
The heart rate was determined during a submaximal work
load before and after the training intervention at 125 W (64% of
average maximal performance before training) and at 150 W
(77% of average maximal performance before training). To this
end, a heart rate monitor was employed (Polar Electro Inc., Kem-
pele, Finland) with a transmitter fastened around the chest.
Hydrostatic weighing
Hydrostatic weighing with simultaneous measurement of
lung volume was used to determine whole body fat percentage in
the morning in the fasted state. The equation of Siri (24) was used
to calculate fat percentage.
Blood sample analysis
Blood samples were collected in EDTA-containing tubes and
immediately centrifuged at high speed. Plasma FAs and glucose
were measured with enzymatic assays automated on a Cobas
Fara/Mira (FAs: Nefa C test kit; Wako Chemicals, Neuss, Ger-
many) (glucose: hexokinase method; Roche, Basel, Switzerland).
Total cholesterol (Cholesterol Oxidase Phenol 4-Aminoan-
tipyrine Peroxidase method; Roche Diagnostics Systems, Hoff-
mann-La Roche, Indianapolis, IN), high-density lipoprotein
(HDL) cholesterol (Cholesterol Oxidase Phenol 4-Amino-
antipyrine Peroxidase method; Roche Diagnostics Systems,
Hoffmann-La Roche) after precipitation of apolipoprotein-B-
containing lipoproteins by adding phosphotungstic acid and
magnesium ions (precipitation method; Monotest cholesterol;
Roche Molecular Biochemicals, Indianapolis, IN), and triacyl-
glycerol (GPO-Trinder; Sigma Diagnostics, St. Louis, MO) were
analyzed in serum enzymatically. All samples from one partici-
pant were analyzed within one analysis at the end of the study
using a semiautomatic ABX Pentra 400 (Horiba ABX, Mont-
pellier, France). The Friedewald equation (25) was used to cal-
culate serum low-density lipoprotein (LDL) cholesterol.
MRI
Measurements were performed on a clinical whole-body MRI
scanner (Intera, 1.5T; Philips Healthcare, Best, The Netherlands)
with a dedicated, five-element cardiac radiofrequency coil. An
electrocardiographically triggered turbo field echo sequence was
used to acquire images in two- and four chamber views and
image the whole heart in the short-axis orientation during breath
holds (24 frames per heart cycle). Due to anxiety in one case and
technical problems in another case, the imaging protocol had to
be shortened and functional parameters could not be determined
in one subject before training, and in another subject after train-
ing. Therefore, the comparison of cardiac function is based on 12
subjects.
Image processing
All images were analyzed quantitatively using dedicated soft-
ware (CAAS; Pie Medical Imaging, Maastricht, The Nether-
lands) to determine left ventricular ejection volume, cardiac out-
put, and cardiac index.
MRS
Cardiac lipid content was determined in vivo by MRS. Signal
acquisition was restricted to a volume of interest of 6 cm3 (10 
20  30 mm) in the septum of the heart (PRESS sequence; spec-
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tral band width  1000 Hz; points acquired  512; echo time 
26 msec; repetition time  4 sec), signal acquisition was ECG
triggered to end systole (310 msec after R-top). Respiratory gat-
ing and tracking was performed with a pencil beam navigator
placed on the diaphragm (19). High efficiency of the navigator-
gated acquisition was achieved by instructing subjects to breath
in the 4s rhythm of the measurement. A spectrum with and with-
out water suppression was acquired as reported earlier for skel-
etal muscle (22). Overall acquisition time (imaging and spec-
troscopy) was 90 min.
Spectral postprocessing
Postprocessing of the spectra was performed with the jMRUI
software (26) as reported earlier for skeletal muscle; however,
only three lipid peaks were fitted with imposing relative ratios of
the amplitudes and line widths, using the AMARES algorithm
(27) (see Fig. 1). The results are displayed as ratios of the am-
plitudes of the CH2 peak relative to the water peak (not corrected
for T1 and T2 relaxation).
Statistics
All data are presented as mean  SEM. Statistical analyses were
performed using SPSS 16.0 for Mac (SPSS Inc., Chicago, IL). The
effect of the intervention was determined by a two-sided, paired
Student t test. To correct/adjust changes in cardiac lipid content
for changes in body weight and fat percentage, a linear regression
analysis was performed with the change in cardiac lipid content
as dependent variable and the changes in body weight and fat




Maximal whole-body oxygen uptake improved with
training (from 2559  131 to 2702  124 ml/min after
training, P  0.05).
Body weight and whole-body fat percentage
Body weight and fat percentage did not change with
training (body weight from 94.2  3.6 to 92.9  3.6 kg,
P  0.10; fat percentage from 33.6  1.7 to 32.5  2.0%
(P  0.14), see Table 1].
Plasma parameters
The training program resulted in a significant decrease
in fasting plasma glucose concentration (from 6.3  0.2 to
5.7  0.2 mmol/liter, P  0.001). Similarly, HbA1c
plasma concentration decreased with training from 5.9 
0.1 to 5.8  0.1% (P  0.012).
Mean FA concentration after an overnight fast was not
affected by training [384.3  37.8 to 364.5  24.4 mol/
liter, before and after training, respectively (P  0.64)].
Mean total cholesterol decreased (from 5.63  0.22 to
5.29  0.22 mmol/liter, P  0.02), and LDL cholesterol
decreased (from 3.74  0.20 to 3.41  0.23 mmol/liter,
P  0.012). Mean HDL cholesterol did not change (1.28 
0.07 before training and 1.28  0.07 mmol/liter after
training (P  0.9)]. Mean plasma triacylglycerol concen-
trations did not change [1.36  0.10 before training and
1.35  0.11 mmol/liter after training (P  0.9)].
Cardiac function
Heart rate during a submaximal cycling protocol at a
workload of 125 W decreased from 127.9  3.6 beats/min
(bpm) to 121.2  3.3 bpm (P  0.05), and at a workload
of 150 W, it decreased from 141.3  4.1 bpm to 131.4 
3.5 bpm (P  0.03), indicating a training-induced increase
in stroke volume. In line with this, multislice CINE-MRI
revealed that ejection fraction was improved after train-
ing [from 52.2  1.3 to 54.2  1.2% (P  0.02), see Fig.
2]. Cardiac index and cardiac output were not signifi-
cantly changed after training [cardiac index: from
3.00  1.48 to 3.01  2.08 liters/min  m2 (P  0.8) and
cardiac output from 6.1  0.3 to 5.8  0.3 liters/min
(P  0.2)]. Changes in ejection fraction correlated neg-
atively with changes in HDL cholesterol (P  0.736, P 
FIG. 1. Typical spectrum. A typical proton magnetic resonance
spectrum, acquired from the septum of the heart. The peak originating
from the CH2 group is depicted. Region 1 depicts the residual water
signal, region 2 shows other cardiac metabolites (creatine and
trimethylammonium), region 3 depicts a lipid peak originating from
chemically diverse protons in the neighborhood of oxygen atoms and
double bonds, and region 4 corresponds to the CH3 peak of cardiac
lipids.
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0.006). Changes in ejection fraction did not correlate
with changes in VO2max (P  0.3).
Cardiac lipid content
Cardiac lipid content significantly decreased after
training (from 0.99  0.15 to 0.54  0.04%, P  0.02, see
Fig. 3). In two individuals, cardiac lipid content was very
high before the intervention. Please note that the training-
induced decrease in cardiac lipid content remains statis-
tically significant after removal of the two outliers (from
0.79  0.08 to 0.54  0.05%, P  0.02). The decrease in
cardiac lipid content was still significant after correction
for changes in body weight and fat percentage by linear
regression (P  0.04). Changes in cardiac lipid content did
not correlate with changes in VO2max (P  0.9).
Discussion
The primary finding of the present study is that cardiac
lipid content is decreased with physical exercise training in
healthy overweight subjects and that this is paralleled by
improved systolic function. It is well known that regular
physical exercise is beneficial to cardiovascular health,
and accordingly, the American Heart Association advises
regular physical activity (20–30 min sessions, at least three
to five times per week, depending on the intensity) (28).
Using multislice CINE-MRI, which is considered the gold
standard for determination of ejection fraction, we dem-
onstrated here that after 12 wk of supervised progressive
exercise training, ejection fraction is improved in obese
male subjects. It has been demonstrated in some, but not
all studies before, that physical exercise programs lead to
improvements in cardiac function (20, 29). Here we
present evidence that indeed, even after a relatively short
period of 12 wk, cardiac function adapts positively, re-
flected by improved ejection fraction and a decreased
heart rate during submaximal exercise. Most importantly,
however, we show here for the first time that cardiac lipid
content can be markedly lowered in healthy obese subjects
by regular exercise training. Cardiac lipid content has been
linked to the development of cardiomyopathy in obese
subjects and diabetic patients. Our results show that even
a relatively short (3 months) training intervention pro-
gram, without major body weight loss, is already able to
markedly lower cardiac lipid content. Even though the im-
provement incardiacfunctionwasonlymodest inthepresent
study, it can be expected that the training-induced reduction
in cardiac lipid content will be beneficial with regard to re-
ducing the risk on cardiomyopathy in the longer term, al-
though future studies are needed to prove this concept.
The decreased lipid content in the heart after exercise
training is opposite to observations in skeletal muscle. In
skeletal muscle, lipid content is increased in response to
physical exercise training, we have shown previously that
2 wk of endurance training was already sufficient to in-
crease intramyocellular lipids content by 42% in healthy
lean subjects (22). Therefore, whereas exercise training is
increasing the storage capacity for intracellular substrate
in skeletal muscle, the present results might indicate that
the reliance on intracellular substrate during exercise is
less pronounced for cardiac muscle. The increased lipid
content with exercise training in skeletal muscle makes
it difficult to use skeletal muscle lipid content as an early
marker of developing insulin resistance because physi-
cal activity can be a confounding factor. In the present
study, we show that for cardiac muscle, this is not the
case. This may have the important implication that car-
diac lipid content could be used as a risk marker for
cardiac deterioration.
Another important finding is that although total body
fat percentage and body weight was unaffected by the
current physical activity training program, it resulted in
partitioning of FAs away from possibly unfavorable stor-
FIG. 3. Cardiac lipid content. Cardiac lipid content before and after
the training intervention. Cardiac lipid content is expressed as the
relative intensity of the CH2 peak, compared with the unsuppressed
water resonance. Cardiac lipid content decreased after the training
intervention (P  0.02). Please note that the training effect persists
after removal of the two outliers (P  0.02).
FIG. 2. Improved systolic function. Left ventricular ejection fraction
improved with the training intervention (P  0.02, n  12).
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age sites in cardiac muscle. Therefore, these results under-
score the power of physical activity in improving health in
obesity, and the present findings should encourage people
that may be disappointed by the lack of cosmetic changes
by physical activity. A limitation of the current study is
that only male subjects were investigated; therefore, it is
yet unknown whether women respond in the same way.
The mechanism underlying the decrease in cardiac fat
deposition is still under investigation. A decreased avail-
ability of plasma lipids after training may play a role. Al-
though in the present study, plasma FAs and triacylglyc-
erol concentrations were not (yet) decreased, we do report
lower total and LDL cholesterol concentrations after
training, which represents a more favorable lipid profile.
Next to a decreased systemic availability of FAs, an
increased capacity for FA oxidation in the myocardium
may underlie the current findings of lowered cardiac lipid
content. In the present study, oxidative capacity of the
heart could not be determined, but the training program
did improve whole-body maximal oxygen uptake. In that
regard, it is interesting to note that in rats, maximal ox-
ygen uptake of isolated cardiomyocytes was indeed higher
after an endurance training intervention (30).
The beneficial effect of training on systolic and diastolic
function has been linked to alterations of the Ca2 regu-
latory systems involved in the excitation-contraction cou-
pling and relaxation processes (30, 31). Interestingly, an
increased supply of long chain fatty acids also may influ-
ence excitation-contraction coupling as well as other pro-
cesses linked to cellular Ca2 handling (32, 33). These
mechanisms may link the exercise induced decrease in
lipid content to the improvement in systolic function. In
line with this reasoning, whereas exercise training de-
creases cardiac lipid content and improves cardiac func-
tion, an increased cardiac lipid content due to high-fat
diets in rodents leads to contractile dysfunction and al-
tered intracellular signaling (15). However, although the
results of the current study are in line with a lipotoxic
action of cardiac lipids on cardiac function, a causal re-
lationship cannot be proven, and it cannot be excluded
that endurance training influences cardiac function and
lipid content independently.
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